Related Experiment Videos
Chordal replacement in mitral valve repair.
R W Frater1, H O Vetter, C Zussa
1Division of Cardiothoracic Surgery, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY.
Circulation
|November 1, 1990
Summary
Glutaraldehyde-tanned xenograft pericardial chordae (GTXP) and extruded polytetrafluoroethylene (ePTFE) chordae show promise for atrioventricular valve repair. Both materials integrate well, with ePTFE maintaining flexibility and GTXP potentially stiffening over time.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Regenerative Medicine
Background:
- Atrioventricular valve repair is crucial for cardiac function.
- Chordal integrity is essential for proper valve leaflet coaptation.
- Limitations exist with current chordal replacement techniques.
Purpose of the Study:
- To evaluate the healing and long-term performance of glutaraldehyde-tanned xenograft pericardial chordae (GTXP) and extruded polytetrafluoroethylene (ePTFE) chordae.
- To compare the biological integration and structural integrity of these two chordal replacement materials.
Main Methods:
- GTXP and ePTFE chordae were implanted for atrioventricular valve repair.
- Histological examination assessed tissue integration with papillary muscles and valve cusps.
- Mechanical properties, including elongation and shrinkage, were monitored.
- Follow-up evaluations assessed clinical outcomes and material durability.
Main Results:
- Both GTXP and ePTFE chordae demonstrated successful healing to native cardiac structures.
- Neither material exhibited significant elongation or shrinkage post-implantation.
- GTXP showed a tendency to thicken and stiffen over time.
- ePTFE was consistently covered by neotissue, forming a new chorda, and retained flexibility, especially in smaller sizes.
Conclusions:
- Chordal replacement using both GTXP and ePTFE offers viable options for atrioventricular valve repair.
- ePTFE appears to offer superior long-term flexibility and tissue integration compared to GTXP.
- Encouraging clinical outcomes support the use of these synthetic chordae in valve reconstruction.